home / stock / imrx / imrx short
Short Information | Immuneering Corporation (NASDAQ:IMRX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,489,071 |
Total Actual Volume | 7,611,749 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 74,454 |
Average Short Percentage | 24.57% |
Is there a IMRX Short Squeeze or Breakout about to happen?
See the IMRX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $1.18 | $1.09 | $1.19 | $1.05 | 590,043 | 224,803 | 38.1% |
07-01-2024 | $1.34 | $1.17 | $1.34 | $1.17 | 354,198 | 82,863 | 23.39% |
06-28-2024 | $1.44 | $1.28 | $1.44 | $1.28 | 2,510,640 | 107,623 | 4.29% |
06-27-2024 | $1.39 | $1.43 | $1.435 | $1.32 | 177,852 | 45,673 | 25.68% |
06-26-2024 | $1.41 | $1.38 | $1.44 | $1.36 | 161,515 | 35,418 | 21.93% |
06-25-2024 | $1.49 | $1.43 | $1.49 | $1.38 | 263,469 | 68,876 | 26.14% |
06-24-2024 | $1.43 | $1.49 | $1.55 | $1.43 | 132,905 | 38,473 | 28.95% |
06-21-2024 | $1.38 | $1.43 | $1.455 | $1.38 | 147,798 | 19,454 | 13.16% |
06-20-2024 | $1.49 | $1.41 | $1.5 | $1.38 | 141,474 | 37,879 | 26.77% |
06-18-2024 | $1.54 | $1.48 | $1.55 | $1.43 | 158,186 | 28,122 | 17.78% |
06-17-2024 | $1.49 | $1.535 | $1.65 | $1.49 | 415,271 | 63,705 | 15.34% |
06-14-2024 | $1.65 | $1.51 | $1.67 | $1.475 | 242,963 | 82,299 | 33.87% |
06-13-2024 | $1.57 | $1.69 | $1.73 | $1.56 | 250,669 | 87,358 | 34.85% |
06-12-2024 | $1.74 | $1.54 | $1.7932 | $1.5 | 249,381 | 74,777 | 29.99% |
06-11-2024 | $1.46 | $1.69 | $2.01 | $1.4116 | 768,076 | 245,204 | 31.92% |
06-10-2024 | $1.36 | $1.49 | $1.5 | $1.3 | 327,023 | 46,034 | 14.08% |
06-07-2024 | $1.39 | $1.37 | $1.4 | $1.32 | 147,254 | 31,666 | 21.5% |
06-06-2024 | $1.37 | $1.41 | $1.42 | $1.35 | 100,682 | 28,084 | 27.89% |
06-05-2024 | $1.35 | $1.38 | $1.4 | $1.33 | 123,815 | 29,365 | 23.72% |
06-04-2024 | $1.35 | $1.34 | $1.38 | $1.32 | 348,535 | 111,395 | 31.96% |
News, Short Squeeze, Breakout and More Instantly...
Immuneering Corporation Company Name:
IMRX Stock Symbol:
NASDAQ Market:
Immuneering Corporation Website:
CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced that management will participate in the Jefferies...
- Reported Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors - - First Patient Dosed in Phase 2a Portion of Phase 1/2a Clinical Trial of IMM-1-104; Initial Data from Multiple IMM-1-104 Phase 2a Arms Expected in 2024 - ...
- Two clinical stage product candidates in development for the treatment of melanoma - - RAS mutant melanoma represents one of five arms in the company’s ongoing Phase 2a clinical study of IMM-1-104 - - Melanoma also being evaluated in ongoing Phase 1/2a clinical study of...